Breadcrumb
NIH Guide: Weekly Index for November 17, 2023
Weekly NIH Funding Opportunities and Notices
November 17, 2023
Policy Notices
-
Special Emphasis Notice: AHRQ Announces Interest in Health Services Research to Improve Healthcare for Persons Living with Disabilities
(NOT-HS-24-004)Agency for Healthcare Research and Quality
-
Reminder to AHRQ Grantees that FY2019 Funds will Expire on September 30, 2024
(NOT-HS-24-005)Agency for Healthcare Research and Quality
-
Clarification of Implementation of the NIH SBIR and STTR Foreign Disclosure Pre-award and Post-Award Requirements
(NOT-OD-24-029)National Institutes of Health
General Notices
-
Notice of Informational Webinar: Intervention Research to Improve Native American Health: Whats New with PAR-23-298, PAR-23-285, PAR-23-299"
(NOT-DA-23-045)National Institute on Drug Abuse
-
Notice of Informational Webinar for the National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32)
(NOT-GM-24-011)National Institute of General Medical Sciences
-
Notice of Pre-Application Webinar for Ethical, Legal and Social Implications (ELSI) Research: PAR-23-293 (R01 Clinical Trial Optional), PAR-23-294 (R21 Clinical Trial Optional) and PAR-23-295 (R03 Clinical Trial Optional)
(NOT-HG-24-010)National Human Genome Research Institute
-
Notice of termination of the NINDS Postdoctoral Mentored Career Development Award K01 (PAR-23-143 and PAR-23-142)
(NOT-NS-24-031)National Institute of Neurological Disorders and Stroke
-
Findings of Research Misconduct
(NOT-OD-24-028)Office of the Director, NIH
-
Extension of Application Receipt Dates for PAR-18-799 NIOSH Mentored Research Scientist Development Award (K01)
(NOT-OH-24-003)National Institute for Occupational Safety and Health
-
Extension of Application Receipt Dates for PAR-18-812 NIOSH Occupational Safety and Health Research (R01)
(NOT-OH-24-004)National Institute for Occupational Safety and Health
-
Extension of Application Receipt Dates for PAR-18-797 NIOSH Small Research Grant Program (R03)
(NOT-OH-24-005)National Institute for Occupational Safety and Health
-
Extension of Application Receipt Dates for PAR-18-798 NIOSH Exploratory/Developmental Grant Program (R21)
(NOT-OH-24-006)National Institute for Occupational Safety and Health
-
Request for Information (RFI): BRAIN Initiative: Brain Behavior Quantification and Synchronization: Guidance for Opportunities in Development of Sensor Technology Hubs
(NOT-MH-24-125)National Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and Bioengineering
Notice of Changes to Funding Opportunities
-
Notice of Early Expiration of PAR-23-174 "Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)"
(NOT-AG-23-064)National Institute on Aging
-
Notice of Change to Key Dates Listed in PAR-23-053 and PAR-23-054
(NOT-AG-23-071)National Institute on Aging
-
Notice to Clarify Eligibility Requirements of Program Directors/Principal Investigators (PDs/PIs) in PAR-24-039 Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
(NOT-CA-24-009)National Cancer Institute
-
Notice of Extension of the Expiration Date for PAR-21-294 "Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)"
(NOT-CA-24-013)National Cancer Institute
-
Notice to Expire NOT-ES-22-003 "Notice of Special Interest (NOSI): KC Donnelly Externship (Admin Supp Clinical Trial Not Allowed)
(NOT-ES-24-001)National Institute of Environmental Health Sciences
-
Notice of Change to Foreign Institution Eligibility in PAR-23-241 "IDeA Clinical & Translational Research Network (CTR-N) Award (P50 - Clinical Trial Optional)"
(NOT-GM-24-009)National Institute of General Medical Sciences
-
Notice of NHGRI Participation in PAR-23-309, Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)
(NOT-HG-24-007)National Human Genome Research Institute
-
Notice of Correction to Expiration Date for PAR-24-063 "Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)"
(NOT-NS-24-030)National Institute of Neurological Disorders and Stroke
Notices of Intent to Publish
Requests for Proposal
-
Pre-Solicitation Notice: Humoral Immunology Core Laboratory for AIDS Vaccine Research, RFP: 75N93023R00012
(NOT-AI-24-005)National Institute of Allergy and Infectious Diseases
Notices of Special Interest
-
Notice of Special Interest (NOSI): Telehealth for People and Families Living with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)
(NOT-AG-23-060)National Institute on Aging
-
Notice of Special Interest: Leveraging Existing and Accessible Datasets for Implementation Research Strategies and Testing - LEAD FIRST
(NOT-HL-23-120)National Heart, Lung, and Blood Institute
-
Notice of Special Interest (NOSI): Administrative Supplements to Support Addiction Science and Related Neuroscience Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI)
(NOT-MD-23-019)National Institute on Minority Health and Health DisparitiesNational Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21)
(NOT-OD-24-026)Office of the Director, NIHNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Library of MedicineNational Institute of Mental HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Research on Women's HealthNational Institute on Minority Health and Health Disparities
Funding Opportunities
-
Initiative for Maximizing Student Development (IMSD) (T32)
(PAR-24-031)National Institute of General Medical SciencesApplication Receipt Date(s): January 29, 2026
-
Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32)
(PAR-24-032)National Institute of General Medical SciencesApplication Receipt Date(s): January 29, 2026
-
Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)
(PAR-24-052)National Institute on AgingApplication Receipt Date(s): January 7, 2027
-
Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses (R25 Independent Clinical Trial Not Allowed)
(PAR-24-061)National Institute of Nursing ResearchOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): May 25, 2026
-
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)
(PAR-24-064)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
Adolescent Overdose Prevention and SUD Treatment Initiative (R21 - Clinical Trial Not Allowed)
(RFA-DA-25-030)National Institute on Drug AbuseNational Institute on Alcohol Abuse and AlcoholismApplication Receipt Date(s): March 13, 2024
-
Adolescent Overdose Prevention and SUD Treatment Initiative (R34 - Clinical Trial Optional)
(RFA-DA-25-031)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed
(RFA-FD-24-005)Food and Drug AdministrationApplication Receipt Date(s): March 31, 2024
-
Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional
(RFA-FD-24-006)Food and Drug AdministrationApplication Receipt Date(s): March 31, 2024
-
Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)
(RFA-FD-24-008)Food and Drug AdministrationApplication Receipt Date(s): March 31, 2024
-
Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional
(RFA-FD-24-009)Food and Drug AdministrationApplication Receipt Date(s): March 31, 2024
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: October 11, 2024
For technical issues E-mail OER Webmaster